三诺生物: 关于不向下修正三诺转债转股价格的公告

Core Points - The company has decided not to adjust the conversion price of its convertible bonds, despite triggering conditions for a downward adjustment due to stock prices falling below 80% of the current conversion price for at least 15 trading days within a 30-day period [1][8] - The next period for potential adjustment will restart from December 22, 2025, if the conditions are triggered again [1][8] Convertible Bond Basic Information - The company issued 5 million convertible bonds at a face value of 100 RMB each, totaling 500 million RMB, which began trading on January 12, 2021 [1][2] - The initial conversion price was set at 35.35 RMB per share [2] Conversion Price Adjustment History - The conversion price was adjusted to 35.15 RMB per share on June 11, 2021, following a cash dividend distribution of 2.00 RMB per 10 shares [2][3] - Subsequent adjustments occurred, with the conversion price changing to 34.98 RMB on May 25, 2022, and further adjustments to 34.81 RMB on May 26, 2023, and 34.61 RMB on June 17, 2024 [3][4][5] Non-Adjustment Decision Explanation - The board of directors considered various factors, including the company's fundamentals and market conditions, before deciding not to adjust the conversion price on June 19, 2025 [8] - The decision aims to maintain the long-term interests of all shareholders and creditors [8]